Ping Wang

6.5k total citations
184 papers, 4.7k citations indexed

About

Ping Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ping Wang has authored 184 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 86 papers in Cancer Research and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ping Wang's work include Cancer-related molecular mechanisms research (68 papers), RNA modifications and cancer (38 papers) and MicroRNA in disease regulation (35 papers). Ping Wang is often cited by papers focused on Cancer-related molecular mechanisms research (68 papers), RNA modifications and cancer (38 papers) and MicroRNA in disease regulation (35 papers). Ping Wang collaborates with scholars based in China, United States and United Kingdom. Ping Wang's co-authors include Yixue Xue, Yunhui Liu, Jun Ma, Zhen Li, Zhiqing Li, Jian Zheng, Yilong Yao, Yunhui Liu, Zhiyong Yuan and Jiajia Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ping Wang

177 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Wang China 36 3.1k 2.7k 747 713 388 184 4.7k
Patrick D. Sutphin United States 28 2.4k 0.8× 1.6k 0.6× 543 0.7× 791 1.1× 307 0.8× 81 3.9k
Valentina Vaira Italy 34 2.3k 0.7× 1.2k 0.4× 641 0.9× 834 1.2× 385 1.0× 115 3.9k
Claudia Cava Italy 22 2.9k 0.9× 2.0k 0.8× 929 1.2× 821 1.2× 132 0.3× 64 4.2k
Weiyi Fang China 37 2.9k 0.9× 1.8k 0.7× 470 0.6× 1.0k 1.5× 219 0.6× 138 4.5k
Jiang Lin China 37 3.2k 1.0× 1.8k 0.7× 326 0.4× 670 0.9× 274 0.7× 258 4.8k
Qi Cao United States 35 6.1k 2.0× 3.3k 1.2× 2.0k 2.6× 915 1.3× 354 0.9× 104 7.9k
Libero Santarpia Italy 37 3.3k 1.1× 2.2k 0.8× 773 1.0× 1.8k 2.6× 247 0.6× 89 5.4k
Shiwu Zhang China 39 2.8k 0.9× 1.5k 0.6× 668 0.9× 1.7k 2.4× 226 0.6× 169 4.7k
Stefanie Galbán United States 29 2.8k 0.9× 912 0.3× 658 0.9× 1.0k 1.4× 280 0.7× 74 4.5k

Countries citing papers authored by Ping Wang

Since Specialization
Citations

This map shows the geographic impact of Ping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wang more than expected).

Fields of papers citing papers by Ping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wang. The network helps show where Ping Wang may publish in the future.

Co-authorship network of co-authors of Ping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Wang. A scholar is included among the top collaborators of Ping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Wang. Ping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Tiefeng, Xiaojing Li, Yi Wang, et al.. (2025). Sodium houttuyfonate prevents NiO-NPs induced lung injury in rats through the TNF-α/JAK-STAT signaling pathway. Ecotoxicology and Environmental Safety. 298. 118306–118306.
2.
Wang, Qingxin, Qifeng Li, Zhongqiu Wang, et al.. (2024). Characterization of a novel VenusX orthogonal dual‐layer multileaf collimator. Journal of Applied Clinical Medical Physics. 25(5). e14357–e14357. 2 indexed citations
3.
Cui, Zheng, et al.. (2024). M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops. Cell Death and Disease. 15(8). 554–554. 5 indexed citations
4.
Li, Tianyun, Xiaobai Liu, Xuelei Ruan, et al.. (2023). A novel peptide P1-121aa encoded by STK24P1 regulates vasculogenic mimicry via ELF2 phosphorylation in glioblastoma. Experimental Neurology. 367. 114477–114477. 3 indexed citations
5.
Pan, Jing, et al.. (2023). Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer. Frontiers in Pharmacology. 14. 1215296–1215296. 1 indexed citations
6.
Meng, Qingxiang, Junhui Li, Hui Zhang, et al.. (2022). ZNF384–ZEB1 feedback loop regulates breast cancer metastasis. Molecular Medicine. 28(1). 111–111. 12 indexed citations
7.
Ren, Wenjing, et al.. (2022). Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer. Scientific Reports. 12(1). 3444–3444. 3 indexed citations
9.
Wang, Jing, Zhiyan Liu, Qingsong Pang, et al.. (2020). Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases. BMC Cancer. 20(1). 837–837. 6 indexed citations
10.
11.
Wang, Xianhuo, Tingting Zhang, Zheng Song, et al.. (2019). Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome. International Journal of Cancer. 145(5). 1414–1422. 27 indexed citations
12.
Shen, Shuyuan, Hai Yu, Xiaobai Liu, et al.. (2017). PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis. Molecular Therapy — Nucleic Acids. 10. 412–425. 60 indexed citations
13.
Que, Zhongyou, Ping Wang, Yi Hu, et al.. (2017). Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling. Pharmacological Research. 119. 72–88. 33 indexed citations
14.
Tao, Zhen, Chenguang Wang, Tingting Zhan, et al.. (2016). Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers In Vitro and In Vivo. Clinical Cancer Research. 22(1). 122–133. 76 indexed citations
15.
Liu, Fengting, Li Jia, Ping Wang, et al.. (2015). CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(10). 2462–2469. 15 indexed citations
16.
Yao, Yilong, Jun Ma, Yixue Xue, et al.. (2015). Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Letters. 359(1). 75–86. 307 indexed citations
17.
Guo, Yu, et al.. (2014). Automatic Lung Tumor Segmentation on PET/CT Images Using Fuzzy Markov Random Field Model. Computational and Mathematical Methods in Medicine. 2014. 1–6. 26 indexed citations
18.
Yao, Yilong, Jun Ma, Yixue Xue, et al.. (2014). MiR‐449a exerts tumor‐suppressive functions in human glioblastoma by targeting Myc‐associated zinc‐finger protein. Molecular Oncology. 9(3). 640–656. 56 indexed citations
19.
Shuai, Yi, Lujun Zhao, Qingsong Pang, et al.. (2011). Clinical analysis of carcinomatous meningitis in 63 cases. Zhonghua fangshe zhongliuxue zazhi. 20(1). 5–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026